Skip to main content

Information for Healthcare Services - Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard

Information for healthcare services to guide practice and monitor improvement using the clinical care standard, and resources to support implementation.

The Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard contains 
eight quality statements describing the expected standard for key components of care. The information below explains what each statement means for healthcare services including the policies, procedures and organisational factors that can enable to delivery of high-quality care. 

Key considerations relating to cultural safety and equity are also included for several quality statements.

A set of indicators is provided to support healthcare services to monitor how well they are implementing the care recommended in this clinical care standard and to support local quality improvement activities. 

What the quality statements mean for healthcare services

Communications resources

A communications kit has been developed to support the launch of the Clinical Care Standard. Show your support for the clinical care standard by downloading and sharing the content on your website, social networks or within your healthcare service.

Resources for healthcare services

See the list of related resources for each quality statement.

The resources below have been developed to support healthcare services to implement the Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard. Other implementation resources are available including guidance for clinicians and resources for consumers.


Meeting the requirements of national standards

Implementing this clinical care standard as part of a quality improvement activity can help healthcare services meet the requirements of the National Safety and Quality Health Service (NSQHS) Standards, and the National Safety and Quality Primary and Community Healthcare Standards (Primary and Community Healthcare Standards).

More information

If you have any questions about the Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard please email ccs@safetyandquality.gov.au

Back to top